line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,NUCLEUS.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.255878,NUCLEUS.NS
Normalized EBITDA,2025-03-31 00:00:00,2346100000.0,NUCLEUS.NS
Total Unusual Items,2025-03-31 00:00:00,,NUCLEUS.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,NUCLEUS.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Reconciled Depreciation,2025-03-31 00:00:00,148100000.0,NUCLEUS.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,5346400000.0,NUCLEUS.NS
EBITDA,2025-03-31 00:00:00,2346100000.0,NUCLEUS.NS
EBIT,2025-03-31 00:00:00,2198000000.0,NUCLEUS.NS
Net Interest Income,2025-03-31 00:00:00,-7500000.0,NUCLEUS.NS
Interest Expense,2025-03-31 00:00:00,7500000.0,NUCLEUS.NS
Interest Income,2025-03-31 00:00:00,,NUCLEUS.NS
Normalized Income,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Total Expenses,2025-03-31 00:00:00,6787100000.0,NUCLEUS.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,NUCLEUS.NS
Diluted Average Shares,2025-03-31 00:00:00,26547231.0,NUCLEUS.NS
Basic Average Shares,2025-03-31 00:00:00,26547231.0,NUCLEUS.NS
Diluted EPS,2025-03-31 00:00:00,61.4,NUCLEUS.NS
Basic EPS,2025-03-31 00:00:00,61.4,NUCLEUS.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Net Income Common Stockholders,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Minority Interests,2025-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Net Income Continuous Operations,2025-03-31 00:00:00,1630000000.0,NUCLEUS.NS
Tax Provision,2025-03-31 00:00:00,560500000.0,NUCLEUS.NS
Pretax Income,2025-03-31 00:00:00,2190500000.0,NUCLEUS.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,662600000.0,NUCLEUS.NS
Special Income Charges,2025-03-31 00:00:00,,NUCLEUS.NS
Other Special Charges,2025-03-31 00:00:00,,NUCLEUS.NS
Write Off,2025-03-31 00:00:00,,NUCLEUS.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-7500000.0,NUCLEUS.NS
Total Other Finance Cost,2025-03-31 00:00:00,,NUCLEUS.NS
Interest Expense Non Operating,2025-03-31 00:00:00,7500000.0,NUCLEUS.NS
Interest Income Non Operating,2025-03-31 00:00:00,,NUCLEUS.NS
Operating Income,2025-03-31 00:00:00,1535400000.0,NUCLEUS.NS
Operating Expense,2025-03-31 00:00:00,1440700000.0,NUCLEUS.NS
Other Operating Expenses,2025-03-31 00:00:00,1292600000.0,NUCLEUS.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,148100000.0,NUCLEUS.NS
Depreciation Income Statement,2025-03-31 00:00:00,148100000.0,NUCLEUS.NS
Selling General And Administration,2025-03-31 00:00:00,,NUCLEUS.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,NUCLEUS.NS
General And Administrative Expense,2025-03-31 00:00:00,,NUCLEUS.NS
Rent And Landing Fees,2025-03-31 00:00:00,,NUCLEUS.NS
Gross Profit,2025-03-31 00:00:00,2976100000.0,NUCLEUS.NS
Cost Of Revenue,2025-03-31 00:00:00,5346400000.0,NUCLEUS.NS
Total Revenue,2025-03-31 00:00:00,8322500000.0,NUCLEUS.NS
Operating Revenue,2025-03-31 00:00:00,8322500000.0,NUCLEUS.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,NUCLEUS.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.250977,NUCLEUS.NS
Normalized EBITDA,2024-03-31 00:00:00,2713000000.0,NUCLEUS.NS
Total Unusual Items,2024-03-31 00:00:00,330700000.0,NUCLEUS.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,330700000.0,NUCLEUS.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Reconciled Depreciation,2024-03-31 00:00:00,145500000.0,NUCLEUS.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,4910600000.0,NUCLEUS.NS
EBITDA,2024-03-31 00:00:00,2713000000.0,NUCLEUS.NS
EBIT,2024-03-31 00:00:00,2567500000.0,NUCLEUS.NS
Net Interest Income,2024-03-31 00:00:00,-9500000.0,NUCLEUS.NS
Interest Expense,2024-03-31 00:00:00,9500000.0,NUCLEUS.NS
Interest Income,2024-03-31 00:00:00,155200000.0,NUCLEUS.NS
Normalized Income,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Total Expenses,2024-03-31 00:00:00,6206000000.0,NUCLEUS.NS
Rent Expense Supplemental,2024-03-31 00:00:00,21800000.0,NUCLEUS.NS
Diluted Average Shares,2024-03-31 00:00:00,26774734.0,NUCLEUS.NS
Basic Average Shares,2024-03-31 00:00:00,26774734.0,NUCLEUS.NS
Diluted EPS,2024-03-31 00:00:00,71.56,NUCLEUS.NS
Basic EPS,2024-03-31 00:00:00,71.56,NUCLEUS.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Net Income Common Stockholders,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Minority Interests,2024-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Net Income Continuous Operations,2024-03-31 00:00:00,1916000000.0,NUCLEUS.NS
Tax Provision,2024-03-31 00:00:00,642000000.0,NUCLEUS.NS
Pretax Income,2024-03-31 00:00:00,2558000000.0,NUCLEUS.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,509000000.0,NUCLEUS.NS
Special Income Charges,2024-03-31 00:00:00,6700000.0,NUCLEUS.NS
Other Special Charges,2024-03-31 00:00:00,-6700000.0,NUCLEUS.NS
Write Off,2024-03-31 00:00:00,,NUCLEUS.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-9500000.0,NUCLEUS.NS
Total Other Finance Cost,2024-03-31 00:00:00,4100000.0,NUCLEUS.NS
Interest Expense Non Operating,2024-03-31 00:00:00,9500000.0,NUCLEUS.NS
Interest Income Non Operating,2024-03-31 00:00:00,155200000.0,NUCLEUS.NS
Operating Income,2024-03-31 00:00:00,2058500000.0,NUCLEUS.NS
Operating Expense,2024-03-31 00:00:00,1295400000.0,NUCLEUS.NS
Other Operating Expenses,2024-03-31 00:00:00,1149900000.0,NUCLEUS.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,145500000.0,NUCLEUS.NS
Depreciation Income Statement,2024-03-31 00:00:00,145500000.0,NUCLEUS.NS
Selling General And Administration,2024-03-31 00:00:00,235500000.0,NUCLEUS.NS
Selling And Marketing Expense,2024-03-31 00:00:00,36700000.0,NUCLEUS.NS
General And Administrative Expense,2024-03-31 00:00:00,198800000.0,NUCLEUS.NS
Rent And Landing Fees,2024-03-31 00:00:00,21800000.0,NUCLEUS.NS
Gross Profit,2024-03-31 00:00:00,3353900000.0,NUCLEUS.NS
Cost Of Revenue,2024-03-31 00:00:00,4910600000.0,NUCLEUS.NS
Total Revenue,2024-03-31 00:00:00,8264500000.0,NUCLEUS.NS
Operating Revenue,2024-03-31 00:00:00,8264500000.0,NUCLEUS.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,55326300.0,NUCLEUS.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.2481,NUCLEUS.NS
Normalized EBITDA,2023-03-31 00:00:00,1681100000.0,NUCLEUS.NS
Total Unusual Items,2023-03-31 00:00:00,223000000.0,NUCLEUS.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,223000000.0,NUCLEUS.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,1277900000.0,NUCLEUS.NS
Reconciled Depreciation,2023-03-31 00:00:00,187300000.0,NUCLEUS.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,4006200000.0,NUCLEUS.NS
EBITDA,2023-03-31 00:00:00,1904100000.0,NUCLEUS.NS
EBIT,2023-03-31 00:00:00,1716800000.0,NUCLEUS.NS
Net Interest Income,2023-03-31 00:00:00,63300000.0,NUCLEUS.NS
Interest Expense,2023-03-31 00:00:00,6000000.0,NUCLEUS.NS
Interest Income,2023-03-31 00:00:00,73500000.0,NUCLEUS.NS
Normalized Income,2023-03-31 00:00:00,1110226300.0,NUCLEUS.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,1277900000.0,NUCLEUS.NS
Total Expenses,2023-03-31 00:00:00,4964200000.0,NUCLEUS.NS
Rent Expense Supplemental,2023-03-31 00:00:00,13000000.0,NUCLEUS.NS
Diluted Average Shares,2023-03-31 00:00:00,26773324.0,NUCLEUS.NS
Basic Average Shares,2023-03-31 00:00:00,26773324.0,NUCLEUS.NS
Diluted EPS,2023-03-31 00:00:00,47.73,NUCLEUS.NS
Basic EPS,2023-03-31 00:00:00,47.73,NUCLEUS.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,1277900000.0,NUCLEUS.NS
Net Income Common Stockholders,2023-03-31 00:00:00,1277900000.0,NUCLEUS.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income,2023-03-31 00:00:00,1277900000.0,NUCLEUS.NS
Minority Interests,2023-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,1277900000.0,NUCLEUS.NS
Net Income Continuous Operations,2023-03-31 00:00:00,1277900000.0,NUCLEUS.NS
Tax Provision,2023-03-31 00:00:00,432900000.0,NUCLEUS.NS
Pretax Income,2023-03-31 00:00:00,1710800000.0,NUCLEUS.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,1300000.0,NUCLEUS.NS
Special Income Charges,2023-03-31 00:00:00,3600000.0,NUCLEUS.NS
Other Special Charges,2023-03-31 00:00:00,-3600000.0,NUCLEUS.NS
Write Off,2023-03-31 00:00:00,4600000.0,NUCLEUS.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,63300000.0,NUCLEUS.NS
Total Other Finance Cost,2023-03-31 00:00:00,4200000.0,NUCLEUS.NS
Interest Expense Non Operating,2023-03-31 00:00:00,6000000.0,NUCLEUS.NS
Interest Income Non Operating,2023-03-31 00:00:00,73500000.0,NUCLEUS.NS
Operating Income,2023-03-31 00:00:00,1380400000.0,NUCLEUS.NS
Operating Expense,2023-03-31 00:00:00,958000000.0,NUCLEUS.NS
Other Operating Expenses,2023-03-31 00:00:00,254100000.0,NUCLEUS.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,187300000.0,NUCLEUS.NS
Depreciation Income Statement,2023-03-31 00:00:00,187300000.0,NUCLEUS.NS
Selling General And Administration,2023-03-31 00:00:00,193900000.0,NUCLEUS.NS
Selling And Marketing Expense,2023-03-31 00:00:00,21300000.0,NUCLEUS.NS
General And Administrative Expense,2023-03-31 00:00:00,172600000.0,NUCLEUS.NS
Rent And Landing Fees,2023-03-31 00:00:00,13000000.0,NUCLEUS.NS
Gross Profit,2023-03-31 00:00:00,2338400000.0,NUCLEUS.NS
Cost Of Revenue,2023-03-31 00:00:00,4006200000.0,NUCLEUS.NS
Total Revenue,2023-03-31 00:00:00,6344600000.0,NUCLEUS.NS
Operating Revenue,2023-03-31 00:00:00,6344600000.0,NUCLEUS.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,58074610.0,NUCLEUS.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.2629,NUCLEUS.NS
Normalized EBITDA,2022-03-31 00:00:00,492300000.0,NUCLEUS.NS
Total Unusual Items,2022-03-31 00:00:00,220900000.0,NUCLEUS.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,220900000.0,NUCLEUS.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,409100000.0,NUCLEUS.NS
Reconciled Depreciation,2022-03-31 00:00:00,153800000.0,NUCLEUS.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,3976200000.0,NUCLEUS.NS
EBITDA,2022-03-31 00:00:00,713200000.0,NUCLEUS.NS
EBIT,2022-03-31 00:00:00,559400000.0,NUCLEUS.NS
Net Interest Income,2022-03-31 00:00:00,89900000.0,NUCLEUS.NS
Interest Expense,2022-03-31 00:00:00,4400000.0,NUCLEUS.NS
Interest Income,2022-03-31 00:00:00,98000000.0,NUCLEUS.NS
Normalized Income,2022-03-31 00:00:00,246274610.0,NUCLEUS.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,409100000.0,NUCLEUS.NS
Total Expenses,2022-03-31 00:00:00,4747200000.0,NUCLEUS.NS
Rent Expense Supplemental,2022-03-31 00:00:00,14300000.0,NUCLEUS.NS
Diluted Average Shares,2022-03-31 00:00:00,28643152.0,NUCLEUS.NS
Basic Average Shares,2022-03-31 00:00:00,28643152.0,NUCLEUS.NS
Diluted EPS,2022-03-31 00:00:00,14.28,NUCLEUS.NS
Basic EPS,2022-03-31 00:00:00,14.28,NUCLEUS.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,409100000.0,NUCLEUS.NS
Net Income Common Stockholders,2022-03-31 00:00:00,409100000.0,NUCLEUS.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income,2022-03-31 00:00:00,409100000.0,NUCLEUS.NS
Minority Interests,2022-03-31 00:00:00,0.0,NUCLEUS.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,409100000.0,NUCLEUS.NS
Net Income Continuous Operations,2022-03-31 00:00:00,409100000.0,NUCLEUS.NS
Tax Provision,2022-03-31 00:00:00,145900000.0,NUCLEUS.NS
Pretax Income,2022-03-31 00:00:00,555000000.0,NUCLEUS.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,5700000.0,NUCLEUS.NS
Special Income Charges,2022-03-31 00:00:00,-7000000.0,NUCLEUS.NS
Other Special Charges,2022-03-31 00:00:00,-1200000.0,NUCLEUS.NS
Write Off,2022-03-31 00:00:00,8200000.0,NUCLEUS.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,89900000.0,NUCLEUS.NS
Total Other Finance Cost,2022-03-31 00:00:00,3700000.0,NUCLEUS.NS
Interest Expense Non Operating,2022-03-31 00:00:00,4400000.0,NUCLEUS.NS
Interest Income Non Operating,2022-03-31 00:00:00,98000000.0,NUCLEUS.NS
Operating Income,2022-03-31 00:00:00,224700000.0,NUCLEUS.NS
Operating Expense,2022-03-31 00:00:00,771000000.0,NUCLEUS.NS
Other Operating Expenses,2022-03-31 00:00:00,158800000.0,NUCLEUS.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,153800000.0,NUCLEUS.NS
Depreciation Income Statement,2022-03-31 00:00:00,153800000.0,NUCLEUS.NS
Selling General And Administration,2022-03-31 00:00:00,196700000.0,NUCLEUS.NS
Selling And Marketing Expense,2022-03-31 00:00:00,15400000.0,NUCLEUS.NS
General And Administrative Expense,2022-03-31 00:00:00,181300000.0,NUCLEUS.NS
Rent And Landing Fees,2022-03-31 00:00:00,14300000.0,NUCLEUS.NS
Gross Profit,2022-03-31 00:00:00,995700000.0,NUCLEUS.NS
Cost Of Revenue,2022-03-31 00:00:00,3976200000.0,NUCLEUS.NS
Total Revenue,2022-03-31 00:00:00,4971900000.0,NUCLEUS.NS
Operating Revenue,2022-03-31 00:00:00,4971900000.0,NUCLEUS.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,NUCLEUS.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,NUCLEUS.NS
Normalized EBITDA,2021-03-31 00:00:00,,NUCLEUS.NS
Total Unusual Items,2021-03-31 00:00:00,254100000.0,NUCLEUS.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,254100000.0,NUCLEUS.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,NUCLEUS.NS
Reconciled Depreciation,2021-03-31 00:00:00,,NUCLEUS.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,NUCLEUS.NS
EBITDA,2021-03-31 00:00:00,,NUCLEUS.NS
EBIT,2021-03-31 00:00:00,,NUCLEUS.NS
Net Interest Income,2021-03-31 00:00:00,,NUCLEUS.NS
Interest Expense,2021-03-31 00:00:00,,NUCLEUS.NS
Interest Income,2021-03-31 00:00:00,136700000.0,NUCLEUS.NS
Normalized Income,2021-03-31 00:00:00,,NUCLEUS.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,NUCLEUS.NS
Total Expenses,2021-03-31 00:00:00,,NUCLEUS.NS
Rent Expense Supplemental,2021-03-31 00:00:00,24900000.0,NUCLEUS.NS
Diluted Average Shares,2021-03-31 00:00:00,,NUCLEUS.NS
Basic Average Shares,2021-03-31 00:00:00,,NUCLEUS.NS
Diluted EPS,2021-03-31 00:00:00,,NUCLEUS.NS
Basic EPS,2021-03-31 00:00:00,,NUCLEUS.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,NUCLEUS.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,NUCLEUS.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,NUCLEUS.NS
Net Income,2021-03-31 00:00:00,,NUCLEUS.NS
Minority Interests,2021-03-31 00:00:00,,NUCLEUS.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,NUCLEUS.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,NUCLEUS.NS
Tax Provision,2021-03-31 00:00:00,,NUCLEUS.NS
Pretax Income,2021-03-31 00:00:00,,NUCLEUS.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,NUCLEUS.NS
Special Income Charges,2021-03-31 00:00:00,32700000.0,NUCLEUS.NS
Other Special Charges,2021-03-31 00:00:00,1100000.0,NUCLEUS.NS
Write Off,2021-03-31 00:00:00,-33800000.0,NUCLEUS.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,NUCLEUS.NS
Total Other Finance Cost,2021-03-31 00:00:00,4100000.0,NUCLEUS.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,NUCLEUS.NS
Interest Income Non Operating,2021-03-31 00:00:00,136700000.0,NUCLEUS.NS
Operating Income,2021-03-31 00:00:00,,NUCLEUS.NS
Operating Expense,2021-03-31 00:00:00,,NUCLEUS.NS
Other Operating Expenses,2021-03-31 00:00:00,,NUCLEUS.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,NUCLEUS.NS
Depreciation Income Statement,2021-03-31 00:00:00,,NUCLEUS.NS
Selling General And Administration,2021-03-31 00:00:00,184700000.0,NUCLEUS.NS
Selling And Marketing Expense,2021-03-31 00:00:00,9400000.0,NUCLEUS.NS
General And Administrative Expense,2021-03-31 00:00:00,175300000.0,NUCLEUS.NS
Rent And Landing Fees,2021-03-31 00:00:00,24900000.0,NUCLEUS.NS
Gross Profit,2021-03-31 00:00:00,,NUCLEUS.NS
Cost Of Revenue,2021-03-31 00:00:00,,NUCLEUS.NS
Total Revenue,2021-03-31 00:00:00,,NUCLEUS.NS
Operating Revenue,2021-03-31 00:00:00,,NUCLEUS.NS
